The table below shows FATE THERAPEUTICS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$30.82M
-$33.81M
-$33.35M
-$28.86M
-$64.61M
-$27.10M
Capital expenditure
$239.00K
$1.20M
$86.00K
$3.21M
$10.08M
$3.98M
Investing cash flow
$23.59M
$42.67M
$17.31M
$9.34M
-$7.03M
-$471.89M
Dividends paid
-
-
-
-
FATE operating cash flow (10-K history)
FATE THERAPEUTICS INC reported operating cash flow of -$106.08M for fiscal year 2025. That is up 13.7% from -$122.87M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$29.82M (FY 2016) to -$106.08M. Figures come from the company's audited annual reports as filed with the SEC.